ARA-290
An EPO-derived peptide studied in nerve and inflammatory-pain research contexts.
Get told when a price moves or a lab test changes.
Observed median price
$67
Every observation
| Date | Observed |
|---|---|
| $51.00 | |
| $103.28 | |
| $49.50 | |
| $49.50 | |
| $49.50 | |
| $49.50 | |
| $49.50 | |
| $51.00 | |
| $72.50 | |
| $72.50 | |
| $72.50 | |
| $72.50 | |
| $72.50 | |
| $72.50 | |
| $72.50 | |
| $72.50 | |
| $72.50 | |
| $72.50 | |
| $72.50 | |
| $72.50 | |
| $72.50 | |
| $72.50 | |
| $72.50 | |
| $72.50 | |
| $72.50 | |
| $72.50 | |
| $72.50 | |
| $72.50 | |
| $72.50 | |
| $72.50 | |
| $72.50 | |
| $72.50 | |
| $72.50 | |
| $72.50 | |
| $75.00 | |
| $67.50 | |
| $60.00 |
Median of 6 listings' 30-day changes; 11 excluded for insufficient history.
17
Active listings
2 · 99.8%
Independent lab tests
$35–$856
Observed price range
4
Known aliases
Read from the certificate, not re-measured by VialGrade. Purity is not a grade. Purity vs grade
Understand this compound
What is ARA-290?
In clinical trialsa.k.a. CibinetideA small piece of EPO (the hormone that makes red blood cells) re-engineered to keep only its tissue-calming, nerve-protecting side. Studied mainly for nerve pain.
Good to know: Despite Phase 2 data and orphan designation, it remains investigational with no regulatory approval anywhere.
How does ARA-290 work?
The science
An 11-amino-acid peptide derived from the tissue-protective domain of erythropoietin that activates the 'innate repair receptor' (an EPO-receptor/beta-common-receptor complex) to reduce inflammation and cell death without stimulating red blood cell production.
Mechanism of action from published research — how the molecule behaves, not a claim about any product or any human-use effect.
What is ARA-290 researched for?
Studied for neuropathic pain and small-fiber neuropathy, particularly in sarcoidosis and type 2 diabetes.
- Recovery & healingStudied in tissue-repair research — tendon, ligament, muscle, and wound-healing models.
- Immune & thymicStudied in immune-modulation and thymic-function research.
How far has the research gone?
In clinical trials — Phase 2 studies have been completed in sarcoidosis-associated neuropathy and diabetic neuropathy; it holds FDA Orphan Drug status but is not approved.
Where the science stands — an approved drug is not the same as the research-grade material a vendor sells, which is unregulated regardless.
What should I check before buying?
- Independent purity. Look for a third-party COA (Janoshik or MZ) showing a measured purity — not just a number the vendor typed.
- Batch match. The strongest evidence is a certificate for the exact batch you’ll receive, attributed to this vendor — check the cross-verification on the listing.
- Vendor reputation. See how the vendor is talked about in the community before trusting a new name.
Research context only — VialGrade never gives dosing, medical, or human-use guidance.
Current market
The ARA-290 market
Every ARA-290 listing we track — 17 in all. The standout picks first where the evidence supports them, then the full table, ranked by what a milligram really costs wherever the vendor published a strength we can read.
Open full marketARA-290 10mg 10-vial kit
Chameleon PeptidesA
$287$2.87/mg-48% vs median
Lowest price per mg that isn't flagged as suspiciously cheap.
UnavailableChecked 4 days ago
ARA-290 10mg 10mg
EZ PeptidesA
$48$4.80/mg-13% vs median
Independently tested at 99.8%.
In stockChecked 11 hours ago
ARA-290 50mg
Ion PeptideC
$179$3.58/mg-35% vs median
The most recently re-verified listing on this market.
In stockChecked 10 hours ago
ARA-290 16mg
Ion PeptideC
$75$4.69/mg-15% vs median
Ranked #3 of 14 listings by price per milligram.
In stockChecked 11 hours ago
ARA-290 10MG
Modern AminosB
$51$5.10/mg-7% vs median
Ranked #5 of 14 listings by price per milligram.
In stockChecked 11 hours ago
Compare by real cost
Every ARA-290 listing, cheapest per mg first
Sticker prices hide the size, so listings are ranked by what a milligram actually costs — with independently tested purity where it exists. All 17 are here: the last 3 are listings whose vendor never published a strength we can read, so they have no per-mg figure to sort on.
| # | Vendor | Size | Price | Per mg | Tested purity | Real $/active mg | |
|---|---|---|---|---|---|---|---|
| 1 | Chameleon PeptidesUnavailable | 100mg total10-vial kit each | $287 | $2.87/mg | — | $2.88/mgbest value | View |
| 2 | Ion Peptide | 50mg total | $179 | $3.58/mg | — | $3.59/mg | View |
| 3 | Ion Peptide | 16mg total | $75 | $4.69/mg | — | $4.70/mg | View |
| 4 | Ez Peptides | 10mg total | $48 | $4.80/mg | 99.8% | $4.81/mg | View |
| 5 | Modern Aminos | 10mg total | $51 | $5.10/mg | — | $5.11/mg | View |
| 6 | Swiss ChemsUnavailable | 160mg totalKIT (10 vials) each | $856 | $5.35/mg | — | $5.36/mg | View |
| 7 | Swiss ChemsUnavailable | 16mg total | $86 | $5.35/mg | — | $5.36/mg | View |
| 8 | Biotech Peptides | 16mg total | $88 | $5.50/mg | — | $5.51/mg | View |
| 9 | Core Peptides | 16mg total | $92 | $5.75/mg | — | $5.76/mg | View |
| 10 | Ion Peptide | 10mg total | $59 | $5.90/mg | — | $5.91/mg | View |
| 11 | Ascension PeptidesUnavailable | 10mg total | $60 | $6.00/mg | — | $6.01/mg | View |
| 12 | Simple Peptide | 10mg total | $76 | $7.60/mg | — | $7.62/mg | View |
| 13 | Umbrella Labs | 4mg total | $40 | $10.00/mg | — | $10.0/mg | View |
| 14 | Chameleon PeptidesUnavailable | 10mg total | $174 | $17.4/mg | — | $17.5/mg | View |
| Listed, but not rankable — no published strength to price per mg | |||||||
| — | Nootropic Source | 1 vial | $35 | no size published | — | — | View |
| — | PurerawzUnavailable | 1 vial | $103 | no size published | — | — | View |
| — | Behemoth LabzUnavailable | 1 vial | $108 | no size published | — | — | View |
Real $/active mg divides the price-per-mg by the measured purity — the honest cost of the actual peptide, so a 90%-pure vial isn’t compared as if it were 99%. Too cheap? flags a listing far below the market rate — often underdosing or a fake, not a deal. The crown marks the cheapest non-outlier; best value marks the lowest real cost per active mg. A vendor shown as Unavailable or Low stock is priced here but not currently buyable.
Independent testing
ARA-290 — independent lab tests
Real, publicly verifiable third-party tests. Purity is read from the certificate itself. A test reflects one lab’s result for one submitted batch — not a guarantee that every vial matches.
How does this data get here?
Every record below is a real certificate of analysis, gathered two ways: from the public verification feeds that independent labs (like Janoshik) publish, and from the certificates vendors post on their own product pages. We open each certificate document and read the measured purity, content, batch, and date directly off it — a scraper can’t read a number printed inside an image, so this is done by machine vision, then recorded here with a link back to the original.
Nothing here is typed in by a vendor or invented by us. Where a certificate is missing, we say so rather than filling the gap.
We re-check the lab feed, too. A “still listed” tag means the certificate is currently public in Janoshik’s database — we re-verify against the live feed and stamp the date. If a cert is later pulled, the tag flips. It’s a freshness check on the same source, not a second independent opinion.
What a certificate does & doesn’t prove
Three different questions. Purity (“how clean?”), identity (“is it the right molecule?”, a mass-spec test), and content (“did I get the labeled mg?”) are separate. A vial can be 99% pure and still be the wrong peptide, or the right peptide underdosed. We flag the measured dose against the label above; underdosing is the most common real fraud.
Who submitted the sample matters. Most of these are vendor-submitted — the seller chose which vial to send, so one good certificate doesn’t prove every batch is the same. The gold standard is a blind test, where a buyer sends a vial they bought as a normal customer. Same label doesn’t prove same product; same batch number doesn’t prove same batch.
99.8%
highest tested purity
Tested batches
Batch test records for ARA-290
The full test history for one batch — who picked the sample, who tested it, and what came back. It describes the vials that were tested, never every vial they sold.
What the research says
Scientific evidence & regulatory status
What the published literature actually shows about ARA-290 — separate from any vendor’s marketing. Each finding links to its paper. This is education, not medical or dosing advice.
Regulatory status
No FDA-approved drug
Not FDA-approved; cibinetide (ARA-290) is an investigational erythropoietin-derived peptide that has only reached small Phase 2 trials. FDA lists it in category 3 of the section 503A compounding nominations — nominated without adequate supporting information.
Research-use-only — not FDA-approved
Sold “for research use only,” this compound is not FDA-approved for human use and has not been evaluated for safety, purity, or sterility in people. It is generally not a scheduled controlled substance, so buying it as a research chemical is typically not itself a drug crime — but marketing or using it as a drug is not lawful, and it is not a dietary supplement.
General information, not legal or medical advice. VialGrade sells nothing and encourages no human use.
Research notes aren’t product proof
Research summaries describe published literature and market data only. They do not establish the identity, quality, safety, or legal status of any listed physical product.